Bio-Rad Laboratories Class B
BIO.B
8 hedge funds and large institutions have $2M invested in Bio-Rad Laboratories Class B in 2023 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, reducing their positions, and 0 closing their positions.
14% more funds holding
Funds holding: 7 → 8 (+1)
0% more ownership
Funds ownership: 0.11% → 0.11% (+0%)
5% less capital invested
Capital invested by funds: $2.1M → $2M (-$105K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JFA
JNBA Financial Advisors
Bloomington,
Minnesota
|
+$744 |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Renaissance Technologies
New York
| $675K | – | – | – |
|
|
CL
2
CSS LLC
Chicago,
Illinois
| $662K | – | – | – |
|
|
BSW
3
Buckingham Strategic Wealth
Clayton,
Missouri
| $270K | – | – | – |
|
4
Morgan Stanley
New York
| $257K | – | – | – |
|
5
Wells Fargo
San Francisco,
California
| $60.4K | – | – | – |
|
|
WT
6
Whittier Trust
South Pasadena,
California
| $56.8K | – | – | – |
|
7
Osaic Holdings
Scottsdale,
Arizona
| $17.8K | – | – | – |
|
|
JFA
8
JNBA Financial Advisors
Bloomington,
Minnesota
| $711 | +$744 | +2 | New |
|
BIO.B Hedge Fund Activity: Q3 2023 in Review
8 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Bio-Rad Laboratories Class B (BIO.B) for Q3 2023, worth a combined $2M — down 5% from $2.1M a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new BIO.B positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.
The largest buyer was JNBA Financial Advisors, opening a new position worth an estimated $744.
- 8 institutional investors held Bio-Rad Laboratories Class B (BIO.B) as of Q3 2023, up from 7 in Q2 2023.
- Funds reported $2M of Bio-Rad Laboratories Class B stock for Q3 2023, down 5% quarter-over-quarter.
- 1 fund opened new Bio-Rad Laboratories Class B positions in Q3 2023 and 0 closed out, a net change of +1 holder.
- The largest Bio-Rad Laboratories Class B buyer in Q3 2023 was JNBA Financial Advisors, an estimated $744 added.
Based on aggregated 13F filings for Q3 2023.